Leslie A. Andritsos, Neil Dunavin, Gerard Lozanski, Jeffrey A. Jones, James S. Blachly, David M. Lucas, John C. Byrd, Eric Kraut, Michael R. Grever. Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective. Haematologica 2014;100(1):e18-e20; https://doi.org/10.3324/haematol.2014.113290.